Experimental group:Camrelizumab combined with SOX

2 trials

Sponsors

The Second Affiliated Hospital of Shandong University, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Conditions

Locally advanced gastric cancergastric or gastroesophageal junction adenocarcinoma

Early Phase 1

Single-center, exploratory clinical trial of camrelizumab combined with SOX regimen for neoadjuvant treatment of locally advanced gastric cancer

RecruitingChiCTR2000034938

The Second Affiliated Hospital of Shandong UniversityLocally advanced gastric cancer

Start: 2020-07-31Updated: 2020-07-27

Phase 2

Camrelizumab combined with or without apatinib and SOX for neoadjuvant treatment of resectable, locally advanced gastric or gastroesophageal junction adenocarcinoma: a prospective, exploratory II trial

Active, not recruitingChiCTR2400093157

Ruijin Hospital, Shanghai Jiao Tong University School of Medicinegastric or gastroesophageal junction adenocarcinoma

Start: 2024-12-01Updated: 2024-12-02